HCA Corporate Compliance Symposium
Thursday, October 6, 2016
1:00 pm - 2:00 pm
Renaissance Albany Hotel
205 Wolf Road
Albany, NY 12207
Barclay Damon, LLP, Partner and Health Care & Human Services Co-Chair, Melissa M. Zambri will present "Legal Ethics in Electronic Health Records and Information Exchange," at the HCA Corporate Compliance Symposium on Thursday October 6,2016. As home care agencies implement new technologies for patient records and expand their connectivity to participating provider networks, they must stay up-to-date on the laws and ethical implications that relate to the use of such Electronic Health Records (EHRs). Melissa M. Zambri will explore the current state of EHRs and highlight associated ethical pitfalls.
HCA’s Corporate Compliance program, on October 6, is a must-attend, highly anticipated annual event which brings together the top state and federal legal experts, state regulators and organizational compliance consultants to keep your team up to date on: new requirements, changes in laws and regulations, tools, resources and best-practices for fulfilling your compliance responsibilities.
Barclay Damon, LLP, listed as a “Top 250 Firm” by The National Law Journal, is a full-service, 275-attorney law firm, with offices throughout the major cities of New York State and in Toronto, Boston, Washington DC, and Newark. Barclay Damon provides comprehensive legal and business counsel to a diverse client base in 33 practice areas. For more information, visit barclaydamon.com.
- Stacy A. Marris Joins Barclay Damon's Rochester Office
- Eric W. Dyer Joins Barclay Damon's Albany Office
- IP practice, patent litigation essential for big firms
- Immigration Attorney Jill Apa Appears on CBC's On The Money
- New York State Appellate Court Holds That Home Care Attendant’s Wage Claims Arising From 24-Hour Shifts May Proceed
- More Changes Coming for New York Not-for-Profits
- Compliance Program Effectiveness: What To Measure and How To Measure It?
- A New Pitfall for Licensors of Multicomponent Inventions – the Supreme Court’s Life Techs Decision